Mitchener Stephen 4
4 · Karyopharm Therapeutics Inc. · Filed Dec 3, 2021
Insider Transaction Report
Form 4
Mitchener Stephen
SVP, Chief Business Officer
Transactions
- Sale
Common Stock
2021-12-02$6.69/sh−499$3,338→ 3,296 total
Footnotes (2)
- [F1]This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary sale by the reporting person.
- [F2]Includes 1,323 shares acquired by the reporting person under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on October 31, 2021.